Skip to content

Ayahuasca for anxiety: all studies

Page 3 of 8: studies 21 to 30 of 73, newest first. Back to the ayahuasca for anxiety overview

Research

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders

Journal of Psychoactive Drugs August 24, 2023 Stanley Wong, An Yi Yu, Nicholas Fabiano et al. 11 citations

There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic" serotonergic psychedelic, has emerged as one of the primary compounds of interest in clinical research. While research on psilocybin's potential mental health benefits has grown, data on the safety and efficacy of other serotonergic psychedelics...

The current state of ayahuasca research in animal models: A systematic review.

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 13, 2023 Dimitri Daldegan-Bueno, Natalia Maria Simionato, Vanessa Manchim Favaro et al. 18 citations

The psychedelic brew ayahuasca is increasingly being investigated for its therapeutic potential. Animal models are essential to investigate the pharmacological effects of ayahuasca since they can control important factors influencing it, such as the set and setting. Review and summarise data available on ayahuasca research using animal models. We systematically searched five databases (PubMed,...

THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE

PARIPEX INDIAN JOURNAL OF RESEARCH May 15, 2023 Chirag Ambaliya, Dimple Gupta, Ashok Vala et al.

The purpose of this review article is to give a summary of the literature on the use of psychedelic drugs, such as psilocybin, LSD, ayahuasca, and MDMA, in the treatment of various mental health conditions, such as depression, anxiety, PTSD, and substance use disorders. This review's main goal is to highlight recent human studies on the use of particular psychedelic drugs, like psilocybin, LSD,...

Psychedelics as Psychiatric Medications

March 1, 2023 David Nutt, David Castle 4 citations

Abstract There is substantial contemporary interest in psychedelic agents as medicines for maladies of the mind. This follows research in the 1950s and 1960s exploring the use of LSD and other psychedelics to treat a range of psychiatric illnesses as well as addictions. This research was shut down after prohibition of these drugs; however, the last decade has seen a major renewal of interest in...

Antidepressant and anxiolytic-like effects of ayahuasca in rats subjected to LPS-induced neuroinflammation

Behavioural Brain Research July 14, 2022 Marina Goulart Da Silva, Guilherme Cabreira Daros, Fabiana Pereira Santos et al. 22 citations

The objective of this study was to evaluate the behavioral response of ayahuasca in rats submitted to neuroinflammation through the intraperitoneal application of lipopolysaccharide (0.63 mg/kg/mL). Eighty animals, male, about 90 days old, were divided into control and LPS groups and later into prevention and treatment subgroups. The prevention subgroup was administered ayahuasca or saline...

Possible Therapeutics Effects of Ayahuasca, a Psychedelic Compound

European Psychiatry June 1, 2022 L. Silva, L. Bravo

Introduction Ayahuasca is an hallucinogenic tea prepared from the Amazonian vine Banisteriopsis caapi and the leaves of the plant Psychotria Viridis. Banisteriopsis caapi contains monoamine oxidase inhibitors (MAO) that render the N, N-dimethyltryptamine (DMT) of Psychotria Viridis active. This brew is being used as a sacrament in syncretic religions in urban areas of Brazil and worldwide with...

Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey

Substance Use & Misuse April 25, 2022 Dimitri Daldegan-Bueno, Dóra Révész, Paulo Rogério Morais et al. 15 citations

Background: Preliminary evidence suggests that long-term ayahuasca use is associated with better psychosocial outcomes and less drug use; however, available data on the association between ayahuasca intake frequency and psychosocial outcomes is limited. Objectives: We sought to characterize and investigate the association of regular ayahuasca use, as compared to non-regular use, on licit...

Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field

Behavioural Brain Research April 1, 2022 Dimitri Daldegan-Bueno, Vanessa Manchim Favaro, Paulo Rogério Morais et al. 10 citations

Considering the long-lasting effects of ayahuasca on the brain and emotional processing, the objective of this study was to evaluate the behavioural and neurobiological effects of repeated ayahuasca administration in an animal model of exploratory behaviour related to novel-environment anxiety. Male Wistar rats received water, 120, 240, 480 or 3600 mg/kg of resuspended freeze-dried ayahuasca by...

The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility

Journal of Psychopharmacology March 1, 2022 Max Wolff, Lea J. Mertens, Marie Walter et al. 57 citations

Background: Many benefits and some harms associated with psychedelic use could be attributable to these drugs’ acceptance/avoidance-promoting effects and corresponding changes in psychological flexibility. Underlying psychological mechanisms are insufficiently understood. Aim: The purpose of this study was the validation of a psychological model of acceptance/avoidance-promoting psychedelic...

Primitivist medicine and capitalist anxieties in ayahuasca tourism Peru

Journal of the Royal Anthropological Institute February 24, 2022 Alex K. Gearin 12 citations

Abstract Analysing healing practices at an ayahuasca tourism centre in Peru, this article illustrates how Shipibo practices of curing and sorcery have adapted to the demands of international clients searching for primitivist healing experiences. At the core of this adaption is the thorny issue of occult power and its relation to capital accumulation. Sorcery here does not serve clients but is...